Advertisement

China probe into alleged Sanofi bribes

Share this article

China probe into alleged Sanofi bribes
View of French pharmaceutical group Sanofi's stand during the Actionaria shareholders event in Paris in 2012. AFP Photo / Eric Piermont
14:22 CEST+02:00
Beijing city health and corruption officials have launched an investigation into allegations staff at French pharmaceutical giant Sanofi bribed more than 500 Chinese doctors a total of about $280,000. Sanofi have said they are taking the allegations "very seriously."

The joint investigation will probe claims in China's 21st Century Business Herald newspaper purporting to show that company staff paid 503 doctors in 79 hospitals bribes totalling 1.69 million yuan in a bid to increase sales.

The paper, citing documents provided by an anonymous whistleblower, said Thursday that in 2007 Sanofi paid doctors 80 yuan ($13) every time a patient bought its products, with the largest payment being 11,200 yuan.

Most of the payments were made to medical staff in hospitals in Beijing, the commercial hub of Shanghai, the southern city of Guangzhou and the eastern city of Hangzhou, and were listed as "research expenses", the report claimed.

The Beijing municipal health bureau will coordinate with the disciplinary authorities to investigate the case, a spokesman told state news agency Xinhua, it reported Saturday.

Sanofi said Thursday that it took the allegations "very seriously".

"We have zero tolerance to any unethical practice," it said in a statement.

"Sanofi has established processes in place for reviewing and addressing such issues in a manner that is consistent with our legal and ethical obligations."

The allegations come after four executives from British drug firm GlaxoSmithKline (GSK) were arrested last month for alleged bribery and other offences.

China's top economic planner is currently investigating 60 foreign and domestic pharmaceutical companies over their prices.
 

Share this article

Advertisement
Advertisement
Advertisement
2,782 Jobs
Click here to start your job search

Latest headlines

Advertisement
Advertisement

Popular articles

Advertisement
Advertisement